The FTC’s latest report exposes PBMs' systematic price-gouging of specialty generics, driving up costs and limiting access to critical medications. The question is, will lawmakers prioritize PBM Reform under the new Trump Administration?
FTC Exposes PBM Price Gouging: Urgent Call…
The FTC’s latest report exposes PBMs' systematic price-gouging of specialty generics, driving up costs and limiting access to critical medications. The question is, will lawmakers prioritize PBM Reform under the new Trump Administration?